Literature DB >> 9705280

Structural requirements for PAK activation by Rac GTPases.

U G Knaus1, Y Wang, A M Reilly, D Warnock, J H Jackson.   

Abstract

The Rho family GTPases, Rac1 and Rac2, regulate a variety of cellular functions including cytoskeletal reorganization, the generation of reactive oxygen species, G1 cell cycle progression and, in concert with Ras, oncogenic transformation. Among the many putative protein targets identified for Rac (and/or Cdc42), the Ser/Thr kinase p21-activated kinase (PAK) is a prime candidate for mediating some of Rac's cellular effects. This report shows that Rac1 binds to and stimulates the kinase activity of PAK1 approximately 2- and 4-5-fold, respectively, better than Rac2. Mutational analysis was employed to determine the structural elements on Rac and PAK that are important for optimal binding and activation. The most notable difference between the highly homologous Rac isomers is the composition of their C-terminal polybasic domains. Mutation of these six basic residues in Rac1 to neutral amino acids dramatically decreased the ability of Rac1 to bind PAK1 and almost completely abolished its ability to stimulate PAK activity. Moreover, replacing the highly charged polybasic domain of Rac1 with the less charged domain of Rac2 (and vice versa) completely reversed the PAK binding/activation properties of the two Rac isomers. Thus, polybasic domain differences account for the disparate abilities of Rac1 and Rac2 to activate PAK. PAK proteins also contain a basic region, consisting of three contiguous lysine residues (Lys66-Lys67-Lys68), which lies outside of the previously identified Cdc42/Rac-binding domain. Mutation of these Lys residues to neutral residues decreased PAK binding to activated Rac1 and Rac2 (but not Cdc42) and greatly reduced PAK1 activation by Rac1, Rac2, and Cdc42 proteins in vivo. In contrast, mutation of lysines 66-68 to basic Arg residues did not decrease (and in some cases enhanced) the ability of Rac1, Rac2, and Cdc42 to bind and activate PAK1. Our studies suggest that the polybasic domain of Rac is a novel effector domain that may allow the two Rac isomers to activate different effector proteins. In addition, our results indicate that a basic region in PAK is required for PAK activation and that binding of Rac/Cdc42 to PAK is not sufficient for kinase activation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9705280     DOI: 10.1074/jbc.273.34.21512

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

Review 1.  PAK and other Rho-associated kinases--effectors with surprisingly diverse mechanisms of regulation.

Authors:  Zhou-shen Zhao; Ed Manser
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

Review 2.  Deconstructing signal transduction pathways that regulate the actin cytoskeleton in dendritic spines.

Authors:  Peter Penzes; Michael E Cahill
Journal:  Cytoskeleton (Hoboken)       Date:  2012-03-12

3.  Phosphoinositides are essential coactivators for p21-activated kinase 1.

Authors:  Todd I Strochlic; Julien Viaud; Ulrike E E Rennefahrt; Theonie Anastassiadis; Jeffrey R Peterson
Journal:  Mol Cell       Date:  2010-11-12       Impact factor: 17.970

Review 4.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

5.  Identification of phosphorylation sites in betaPIX and PAK1.

Authors:  Mark W Mayhew; Erin D Jeffery; Nicholas E Sherman; Kristina Nelson; Joy M Polefrone; Stephen J Pratt; Jeffrey Shabanowitz; J Thomas Parsons; Jay W Fox; Donald F Hunt; Alan F Horwitz
Journal:  J Cell Sci       Date:  2007-11-15       Impact factor: 5.285

6.  Gq-mediated Akt translocation to the membrane: a novel PIP3-independent mechanism in platelets.

Authors:  Rachit Badolia; Bhanu Kanth Manne; Carol Dangelmaier; Jonathan Chernoff; Satya P Kunapuli
Journal:  Blood       Date:  2014-10-20       Impact factor: 22.113

7.  The subcellular localization of type I p21-activated kinases is controlled by the disordered variable region and polybasic sequences.

Authors:  Xiaowen Sun; Valerie L Su; David A Calderwood
Journal:  J Biol Chem       Date:  2019-08-07       Impact factor: 5.157

8.  Increased smooth muscle cell activation and neointima formation in response to injury in AIF-1 transgenic mice.

Authors:  Laura J Sommerville; Sheri E Kelemen; Michael V Autieri
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-11-08       Impact factor: 8.311

9.  P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor β expression and enhanced matrix metalloproteinase 9 secretion.

Authors:  Anna Goc; Ahmad Al-Azayzih; Maha Abdalla; Belal Al-Husein; Sravankumar Kavuri; Jeffrey Lee; Kelvin Moses; Payaningal R Somanath
Journal:  J Biol Chem       Date:  2012-12-20       Impact factor: 5.157

10.  RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma.

Authors:  Abdel Kareem Azab; Feda Azab; Simona Blotta; Costas M Pitsillides; Brian Thompson; Judith M Runnels; Aldo M Roccaro; Hai T Ngo; Molly R Melhem; Antonio Sacco; Xiaoying Jia; Kenneth C Anderson; Charles P Lin; Barrett J Rollins; Irene M Ghobrial
Journal:  Blood       Date:  2009-05-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.